Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE).
Duvignaud A, Etafo IC, Jaspard M, Salau Q, Serra B, Kareem AJ, Juchet S, Jegede TO, Gabillard D, Abidoye AT, Le Gal C, Abejegah C, Owhin S, Okwaraeke K, Doutchi M, Katembo Vihundira J, Besong-Lache RM, Seri B, Bérerd-Camara M, Salam APA, Olayinka A, Horby P, Ogbaini-Emovon E, Duraffour S, Ahmed LA, Günther S, Adedosu AN, Anglaret X, Malvy D, Lang HJ, Ayodeji OO. Duvignaud A, et al. Among authors: olayinka a. J Pediatric Infect Dis Soc. 2024 Nov 4;13(10):513-522. doi: 10.1093/jpids/piae083. J Pediatric Infect Dis Soc. 2024. PMID: 39167706
Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study.
Chandra NL, Bolt H, Dan-Nwafor C, Ipadeola O, Ilori E, Namara G, Olayinka AT, Ukponu W, Iniobong A, Amedu M, Akano A, Akabike KO, Okhuarobo U, Fagbemi S, Sampson E, Newitt S, Verlander NQ, Bausch DG, le Polain de Waroux O, Ihekweazu C. Chandra NL, et al. Among authors: olayinka at. BMC Infect Dis. 2021 Feb 4;21(1):143. doi: 10.1186/s12879-021-05822-4. BMC Infect Dis. 2021. PMID: 33541278 Free PMC article.
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever.
Olayinka AT, Bourner J, Akpede GO, Okoeguale J, Abejegah C, Ajayi NA, Akude C, Ayodeji O, Bausch DG, de Clerck H, Dan-Nwafor C, Dunning J, Erameh C, Eze JN, Formenty P, Gillesen A, Jalloh S, Jaspard M, Jegede T, Maikere J, Malvy D, Ogbaini-Emovon E, Ojo OE, Okogbenin S, O'Neill K, Orji ML, Owhin SO, Ramharter M, Samuels RJ, Shehu N, Merson L, Salam AP, Kayem ND, Horby P, Ihekweazu C, Olliaro P. Olayinka AT, et al. PLoS Negl Trop Dis. 2022 Jan 6;16(1):e0010089. doi: 10.1371/journal.pntd.0010089. eCollection 2022 Jan. PLoS Negl Trop Dis. 2022. PMID: 34990453 Free PMC article.
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN, Fischer WA 2nd, Garry RF, Grant DS, Happi C, N'Faly M, Olayinka A, Samuels R, Sibley J, Wohl DA, Accrombessi M, Adetifa I, Annibaldis G, Camacho A, Dan-Nwafor C, Deha ARE, DeMarco J, Duraffour S, Goba A, Grais R, Günther S, Honvou ÉJJP, Ihekweazu C, Jacobsen C, Kanneh L, Momoh M, Ndiaye A, Nsaibirni R, Okogbenin S, Ochu C, Ogbaini E, Logbo ÉPMA, Sandi JD, Schieffelin JS, Verstraeten T, Vielle NJ, Yadouleton A, Yovo EK; Enable Protocol authorship group. Penfold S, et al. Among authors: olayinka a. PLoS One. 2023 Mar 30;18(3):e0283643. doi: 10.1371/journal.pone.0283643. eCollection 2023. PLoS One. 2023. PMID: 36996258 Free PMC article.
Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study.
Elsinga J, Sunyoto T, di Stefano L, Giorgetti PF, Kyi HA, Burzio C, Campos Moreno X, Ojide CK, Ajayi N, Ewah R, Ogah EO, Dan-Nwafor C, Ahumibe A, Ochu CL, Olayinka A, Jonckheere S, Chaillet P, van Herp M. Elsinga J, et al. Among authors: olayinka a. Lancet Infect Dis. 2024 Sep;24(9):1037-1044. doi: 10.1016/S1473-3099(24)00184-1. Epub 2024 May 8. Lancet Infect Dis. 2024. PMID: 38734012 Free article.
Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.
Dan-Nwafor CC, Furuse Y, Ilori EA, Ipadeola O, Akabike KO, Ahumibe A, Ukponu W, Bakare L, Okwor TJ, Joseph G, Mba NG, Akano A, Olayinka AT, Okoli I, Okea RA, Makava F, Ugbogulu N, Oladele S, Namara G, Muwanguzi EN, Naidoo D, Mutbam SK, Okudo I, Woldetsadik SF, Lasuba CL, Ihekweazu C. Dan-Nwafor CC, et al. Among authors: olayinka at. Euro Surveill. 2019 May;24(20):1900272. doi: 10.2807/1560-7917.ES.2019.24.20.1900272. Euro Surveill. 2019. PMID: 31115314 Free PMC article.
Research as a pillar of Lassa fever emergency response: lessons from Nigeria.
Olayinka AT, Nwafor CD, Akano A, Jan K, Ebhodaghe B, Elimian K, Ochu C, Okwor T, Ipadeola O, Ukponu W, Okudo I, Peter C, Ilori E, Ihekweazu C. Olayinka AT, et al. Pan Afr Med J. 2020 Oct 27;37:179. doi: 10.11604/pamj.2020.37.179.26425. eCollection 2020. Pan Afr Med J. 2020. PMID: 33447334 Free PMC article.
Pathogens that Cause Illness Clinically Indistinguishable from Lassa Fever, Nigeria, 2018.
Ashcroft JW, Olayinka A, Ndodo N, Lewandowski K, Curran MD, Nwafor CD, Madubuike K, Bagnall H, Musa AS, Ahmad A, Akinpelu A, Adeleye A, Martin C, Akano A, Onoja M, Iniobong A, Ukponu W, Arinze C, Ilori E, Mba N, Gannon B, Ahumibe A, Ihekweazu C. Ashcroft JW, et al. Among authors: olayinka a. Emerg Infect Dis. 2022 May;28(5):994-997. doi: 10.3201/eid2805.211153. Epub 2022 Feb 28. Emerg Infect Dis. 2022. PMID: 35226800 Free PMC article.
Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
Dalhat MM, Olayinka A, Meremikwu MM, Dan-Nwafor C, Iniobong A, Ntoimo LF, Onoh I, Mba S, Ohonsi C, Arinze C, Esu EB, Nwafor O, Oladipupo I, Onoja M, Ilori E, Okonofua F, Ochu CL, Igumbor EU, Adetifa I. Dalhat MM, et al. Among authors: olayinka a. PLoS One. 2022 Dec 30;17(12):e0279467. doi: 10.1371/journal.pone.0279467. eCollection 2022. PLoS One. 2022. PMID: 36584167 Free PMC article.
Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria.
Olayinka AT, Elimian K, Ipadeola O, Dan-Nwafor C, Gibson J, Ochu C, Furuse Y, Iniobong A, Akano A, Enenche L, Onoja M, Uzoho C, Ugbogulu N, Makava F, Arinze C, Namara G, Muwanguzi E, Jan K, Ukponu W, Okwor T, Anueyiagu C, Saleh M, Ahumibe A, Eneh C, Ilori E, Mba N, Ihekweazu C. Olayinka AT, et al. PLOS Glob Public Health. 2022 Aug 26;2(8):e0000191. doi: 10.1371/journal.pgph.0000191. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962735 Free PMC article.
101 results